Intranasal nerve growth factor bypasses the bloodbrain barrier and affects spinal cord neurons in spinal cord injury

Neural Regeneration Research

Volumn 9, Issue 10, 2014, Pages 1025-1030

  Aloe, Luigi ^a   Bianchi, Patrizia ^a   De Bellis, Alberto ^b   Soligo, Marzia ^c   Rocco, Maria Luisa ^a  

^a CNR   (Italy)

^b Maria Rosaria Maglione Foundation Onlus   (Italy)

^c INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

Bloodbrain barrier; Intranasal delivery; Leptin; Motor function; Nerve growth factor; Nerve regeneration; Neural regeneration; Neuroprotection; Rats; Spinal cord injury

Indexed keywords

LEPTIN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE A;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; WESTERN BLOTTING;

EID: 84902117975     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.133161     Document Type: Article

References (37)

1. Alcala-Barraza SR, Lee MS, Hanson LR, McDonald AA, Frey WH, 2nd, McLoon LK (2010) Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target 18:179-190.
2. Aloe L, Calza L (2004) NGF and related molecules in health and disease. Amsterdam, New York: Elsevier.
3. Bianchi P, Rocco ML, De bellis A, Aloe L (2012) Effect of intranasal NGF adminstation in injured spinal cord and leptin levels in adult rats. Adipobiology 4:67-75.
4. Bocchini V, Angeletti PU (1969) The nerve growth factor: purification as a 30, 000-molecular-weight protein. Proc Natl Acad Sci U S A 64:787-794.
5. Brandoli C, Shi B, Pflug B, Andrews P, Wrathall JR, Mocchetti I (2001) Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cord. Brain Res Mol Brain Res 87:61-70.
6. Brown A, Ricci MJ, Weaver LC (2007) NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the rat. Exp Neurol 205:283-286.
7. Chen XQ, Fawcett JR, Rahman YE, Ala TA, Frey IW (1998) Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimers Dis 1:35-44.
8. Connor B, Dragunow M (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 27:1-39.
9. Davis-Lopez de Carrizosa MA, Morado-Diaz CJ, Morcuende S, de la Cruz RR, Pastor AM (2010) Nerve growth factor regulates the firing patterns and synaptic composition of motoneurons. J Neurosci 30:8308-8319.
10. De Bellis A, Rocco ML, Bianchi P, Aloe L (2012) Effect of intranasal NGF administration in rats with injured spinal cord. Prog Neurosci 1:83-90.
11. Di Fausto V, Fiore M, Tirassa P, Lambiase A, Aloe L (2007) Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur J Neurosci 26:2473-2480.
12. Di Marco A, Demartis A, Gloaguen I, Lazzaro D, Delmastro P, Ciliberto G, Laufer R (2000) Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin. FEBS J 267:2939-2944.
13. Fernandez-Martos CM, Gonzalez P, Rodriguez FJ (2012) Acute leptin treatment enhances functional recovery after spinal cord injury. PLoS One 7:e35594.
14. Ferri CC, Ghasemlou N, Bisby MA, Kawaja MD (2002) Nerve growth factor alters p75 neurotrophin receptor-induced effects in mouse facial motoneurons following axotomy. Brain Res 950:180-185.
15. Gezici AR, Ergun R, Karakas A, Gunduz B (2009) Serum leptin levels following acute experimental spinal cord injury. J Spinal Cord Med 32:416-421.
16. Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N, Casadesus G (2010) Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 19:1155-1167.
17. Harvey J (2007) Leptin: a diverse regulator of neuronal function. J Neurochem 100:307-313.
18. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677-736.
19. Illum L (2000) Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1-18.
20. Koevary SB, Lam V, Patsiopoulos G, Lake S (2003) Accumulation of porcine insulin in the rat brain and cerebrospinal fluid following ocular application. J Ocul Pharmacol Ther 19:377-384.
21. Krenz NR, Weaver LC (2000) Nerve growth factor in glia and inflammatory cells of the injured rat spinal cord. J Neurochem 74:730-739.
22. Lambiase A, Tirassa P, Micera A, Aloe L, Bonini S (2005) Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci 46:3800-3806.
23. Lambiase A, Pagani L, Di Fausto V, Sposato V, Coassin M, Bonini S, Aloe L (2007) Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res 1127:45-51.
24. Lambiase A, Aloe L, Centofanti M, Parisi V, Mantelli F, Colafrancesco V, Manni GL, Bucci MG, Bonini S, Levi-Montalcini R (2009) Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc Natl Acad Sci U S A 106:13469-13474.
25. Levi-Montalcini R (1987) The nerve growth factor: thirty-five years later. Biosci Rep 7:681-699.
26. Liu J, Chen SS, Dan QQ, Rong R, Zhou X, Zhang LF, Wang TH (2011) Crucial roles of NGF in dorsal horn plasticity in partially deafferentated cats. Growth Factors 29:49-56.
27. Malik-Hall M, Dina OA, Levine JD (2005) Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur J Neurosci 21:3387-3394.
28. Maruyama Y, Mizuguchi M, Yaginuma T, Kusaka M, Yoshida H, Yokoyama K, Kasahara Y, Hosoya T (2008) Serum leptin, abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injury. Spinal Cord 46:494-499.
29. Montazeri F, Esmaeili A, Miroliaei M, Moshtaghian SJ (2013) Messenger RNA expression patterns of p75 neurotrophin receptor and tropomyosin-receptor-kinase A following spinal cord injury. J Spinal Cord Med 36:231-236.
30. Obata K, Katsura H, Mizushima T, Yamanaka H, Kobayashi K, Dai Y, Fukuoka T, Tokunaga A, Tominaga M, Noguchi K (2005) TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J Clin Invest 115:2393-2401.
31. Pan W, Banks WA, Kastin AJ (1998) Permeability of the blood-brain barrier to neurotrophins. Brain Res 788:87-94.
32. Sharma HS (2010) Selected combination of neurotrophins potentiate neuroprotection and functional recovery following spinal cord injury in the rat. Acta Neurochir Suppl 106:295-300.
33. Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217-1281.
34. Soligo M, Nori SL, Protto V, Florenzano F, Manni L (2013) Acupuncture and neurotrophin modulation. Int Rev Neurobiol 111:91-124.
35. Thorne RG, Emory CR, Ala TA, Frey WH, 2nd (1995) Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res 692:278-282.
36. Tuszynski MH, Peterson DA, Ray J, Baird A, Nakahara Y, Gage FH (1994) Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol 126:1-14.
37. Yang JP, Liu HJ, Wang ZL, Cheng SM, Cheng X, Xu GL, Liu XF (2009) The dose-effectiveness of intranasal VEGF in treatment of experimental stroke. Neurosci Lett 461:212-216.